FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2626008046> ?p ?o ?g. }

• W2626008046 endingPage "2008" @default.
• W2626008046 startingPage "1995" @default.
• W2626008046 abstract "Objective: Prostate cancer is a highly prevalent form of cancer in older men and is one of the leading causes of death from cancer in men across the globe. Many therapeutic agents have been approved for patients with metastatic castration-resistant prostate cancer (mCRPC), particularly as a post-docetaxel treatment strategy. The objective of this systematic literature review was to assess published efficacy and safety data for select mCRPC therapies – such as abiraterone, cabazitaxel, and enzalutamide – in the post-docetaxel setting.Methods: Database searches of MEDLINE, Embase, and Cochrane CENTRAL, in conjunction with hand searches of multiple congress abstracts, yielded 13 randomized studies and 107 non-randomized studies that met the inclusion criteria.Results: Randomized studies demonstrated significant improvements in median overall survival (OS) outcomes over placebo for abiraterone (15.8 vs. 11.2 months) and enzalutamide (18.4 vs. 13.6 months), and similar significant improvements were noted for cabazitaxel over mitoxantrone (15.1 vs. 12.7 months). Differences in progression-free survival (PFS) were similarly significant, although variance in the criteria for measuring PFS may limit the extent to which these outcomes can be compared between studies. Non-randomized evidence included multiple publications from several early access and compassionate use programs with a primary objective to report safety outcomes. Results from these studies largely reflected the findings in randomized trials.Conclusions: Overall, there is a growing body of evidence for post-docetaxel treatment options available in patients with mCRPC. Further head-to-head trials or indirect treatment comparisons may be a valuable method to assess the comparative efficacy of these therapies." @default.
• W2626008046 created "2017-06-23" @default.
• W2626008046 creator A5008133506 @default.
• W2626008046 creator A5014525306 @default.
• W2626008046 creator A5024138256 @default.
• W2626008046 creator A5073246821 @default.
• W2626008046 creator A5083311773 @default.
• W2626008046 date "2017-07-10" @default.
• W2626008046 modified "2023-10-04" @default.
• W2626008046 title "Efficacy and safety of post-docetaxel therapies in metastatic castration-resistant prostate cancer: a systematic review of the literature" @default.
• W2626008046 cites W123190302 @default.
• W2626008046 cites W1512914561 @default.
• W2626008046 cites W1529825793 @default.
• W2626008046 cites W1606511994 @default.
• W2626008046 cites W1782284105 @default.
• W2626008046 cites W1932630807 @default.
• W2626008046 cites W1965002585 @default.
• W2626008046 cites W1966225993 @default.
• W2626008046 cites W1979811833 @default.
• W2626008046 cites W1980244461 @default.
• W2626008046 cites W1980797382 @default.
• W2626008046 cites W1982445990 @default.
• W2626008046 cites W1991233593 @default.
• W2626008046 cites W1996389184 @default.
• W2626008046 cites W2004447184 @default.
• W2626008046 cites W2004523378 @default.
• W2626008046 cites W2017663593 @default.
• W2626008046 cites W2041956823 @default.
• W2626008046 cites W2055557358 @default.
• W2626008046 cites W2062392807 @default.
• W2626008046 cites W2066112327 @default.
• W2626008046 cites W2077447317 @default.
• W2626008046 cites W2078559150 @default.
• W2626008046 cites W2078699963 @default.
• W2626008046 cites W2081110856 @default.
• W2626008046 cites W2082715068 @default.
• W2626008046 cites W2097712441 @default.
• W2626008046 cites W2102966185 @default.
• W2626008046 cites W2110194568 @default.
• W2626008046 cites W2110534364 @default.
• W2626008046 cites W2114488753 @default.
• W2626008046 cites W2119529210 @default.
• W2626008046 cites W2119726718 @default.
• W2626008046 cites W2120292596 @default.
• W2626008046 cites W2123526148 @default.
• W2626008046 cites W2128373662 @default.
• W2626008046 cites W2131952914 @default.
• W2626008046 cites W2132019398 @default.
• W2626008046 cites W2138809580 @default.
• W2626008046 cites W2138881017 @default.
• W2626008046 cites W2140056658 @default.
• W2626008046 cites W2140665438 @default.
• W2626008046 cites W2141453591 @default.
• W2626008046 cites W2144700396 @default.
• W2626008046 cites W2144827656 @default.
• W2626008046 cites W2145434047 @default.
• W2626008046 cites W2148643283 @default.
• W2626008046 cites W2167726449 @default.
• W2626008046 cites W2168108459 @default.
• W2626008046 cites W2170731023 @default.
• W2626008046 cites W2172250854 @default.
• W2626008046 cites W2235405584 @default.
• W2626008046 cites W2256491598 @default.
• W2626008046 cites W2278392405 @default.
• W2626008046 cites W2286152207 @default.
• W2626008046 cites W2289695018 @default.
• W2626008046 cites W2303620351 @default.
• W2626008046 cites W2344747506 @default.
• W2626008046 cites W2463867199 @default.
• W2626008046 cites W2484376512 @default.
• W2626008046 cites W2533072646 @default.
• W2626008046 cites W2560686737 @default.
• W2626008046 cites W2589845275 @default.
• W2626008046 cites W2590471156 @default.
• W2626008046 cites W2590615916 @default.
• W2626008046 cites W2590679686 @default.
• W2626008046 cites W2595859672 @default.
• W2626008046 cites W2604251599 @default.
• W2626008046 cites W2917837889 @default.
• W2626008046 cites W2952789992 @default.
• W2626008046 cites W2968566719 @default.
• W2626008046 cites W3011150085 @default.
• W2626008046 cites W3166582654 @default.
• W2626008046 cites W4244970282 @default.
• W2626008046 doi "https://doi.org/10.1080/03007995.2017.1341869" @default.
• W2626008046 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28604117" @default.
• W2626008046 hasPublicationYear "2017" @default.
• W2626008046 type Work @default.
• W2626008046 sameAs 2626008046 @default.
• W2626008046 citedByCount "17" @default.
• W2626008046 countsByYear W26260080462017 @default.
• W2626008046 countsByYear W26260080462018 @default.
• W2626008046 countsByYear W26260080462019 @default.
• W2626008046 countsByYear W26260080462020 @default.
• W2626008046 countsByYear W26260080462021 @default.
• W2626008046 countsByYear W26260080462022 @default.
• W2626008046 countsByYear W26260080462023 @default.
• W2626008046 crossrefType "journal-article" @default.

• next